Compare CLST & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLST | ZTEK |
|---|---|---|
| Founded | 1922 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.9M | 68.8M |
| IPO Year | 2021 | 2022 |
| Metric | CLST | ZTEK |
|---|---|---|
| Price | $16.51 | $0.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.4K | ★ 126.5K |
| Earning Date | 04-23-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $38.28 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.67 | $0.54 |
| 52 Week High | $16.98 | $1.84 |
| Indicator | CLST | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 35.37 |
| Support Level | $16.40 | $0.55 |
| Resistance Level | $16.98 | $0.75 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 44.00 | 27.77 |
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.